Genetic tests to identify people at higher risk of heart failure
By Alicia Bienkowski | Advanced Clinical and Translational Cardiovascular Imaging, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Centre for Diabetes Research, Heart, Lab, Media Releases, News & Events, ResearchA groundbreaking study by researchers at Perth’s Harry Perkins Institute of Medical Research has produced a genetic test for heart failure, which will enable early intervention and more personalised treatment…
New technology revealing genetics of recurrent pregnancy loss
By Cam Findlay | Community, Disease Area, Genes, Genetic Disease, Genome Biology and Genetic Diseases, Lab, News & Events, Rare Disease Genetics and Functional Genomics, Research AreaEvery day in Australia, 282 women experience a miscarriage, according to the The Pink Elephants Support Network. Chromosomal abnormalities are one of the more commonly recognised causes of recurrent miscarriage.…
Researchers discover blood markers that could predict mesothelioma treatment success
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer Epigenetics, Cancer Program, Cell Signalling, Lab, Mesothelioma, News & Events, ResearchA groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research (the Perkins) has identified…
Perth gains NATA-accreditation for rare disease diagnostic tool
By Richard Schoonraad | Disease Area, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, News & Events, Research, Research AreaResearchers at Perth’s Harry Perkins Institute of Medical Research and PathWest Laboratory Medicine WA are celebrating the long-awaited nationally recognised accreditation of a world-leading diagnostic technology that will provide faster,…
$10 million raised for WA Cancer Research
By Richard Schoonraad | Cancer, Events, Fundraising, Media Releases, News & Events, Perkins EventsWest Australians give record amount in Australia’s biggest charity ride. This morning it was announced a record $10,104,999 has been raised for WA cancer research by the nation’s biggest charity…
Federal funding helps WA Biotech firm save lives
By Alicia Bienkowski | Disease Area, Funding, Lab, Media Releases, News & Events, Research, Research AreaCytophenix, a WA biotech startup led by Perkins Researcher Dr Kieran Mulroney, has been awarded a $500,000 grant as part of the Brandon BioCatalyst’s CUREator Incubator’s Health Security funding stream. …
Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
Genetic Variants Linked to Severe Form of Muscular Dystrophy
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchResearchers from Perth’s Harry Perkins Institute of Medical Research have led a study that uncovered changes in a gene associated with a rare and severe form of muscular dystrophy. The…